ArticleDiagnostics (Basel, Switzerland)2026
Discordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients with MASLD: Results from the OBREDI-TR Study.
Ozge Kama Basci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.